(Q34354587)

1 August 2017

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer (English)

1 reference

1 August 2017

1 reference

1 reference

S Hasegawa

1

1 reference

1 August 2017

H Eguchi

2

1 reference

1 August 2017

H Nagano

3

1 reference

1 August 2017

M Konno

4

1 reference

1 August 2017

Y Tomimaru

5

1 reference

1 August 2017

H Wada

6

1 reference

1 August 2017

N Hama

7

1 reference

1 August 2017

K Kawamoto

8

1 reference

1 August 2017

S Kobayashi

9

1 reference

1 August 2017

N Nishida

10

1 reference

1 August 2017

J Koseki

11

1 reference

1 August 2017

T Nishimura

12

1 reference

1 August 2017

N Gotoh

13

1 reference

1 August 2017

S Ohno

14

1 reference

1 August 2017

N Yabuta

15

1 reference

1 August 2017

H Nojima

16

1 reference

1 August 2017

M Mori

17

1 reference

1 August 2017

Y Doki

18

1 reference

1 August 2017

H Ishii

19

1 reference

1 August 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

British Journal of Cancer

1 August 2017

1 reference

1 August 2017

111

1 reference

1 August 2017

8

1 reference

1 August 2017

1572-1580

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2014.454

1 August 2017

0 references

cites work

MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Changes in the expression of cyclin G2 in esophageal cancer cell and its significance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Change in expression of cyclin G2 in kidney cancer cell and its significance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Eyes wide open: a critical review of sphere-formation as an assay for stem cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Dysregulation of miR-15a and miR-214 in human pancreatic cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Changes in expression of cell-cycle-related genes in PC-3 prostate cancer cells caused by ovine uterine serpin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

MicroRNAs: target recognition and regulatory functions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Identification of pancreatic cancer stem cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Deaths: final data for 2003.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Cyclin G2 dysregulation in human oral cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Characterisation of human cyclin G1 and G2: DNA damage inducible genes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2014.454

Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2014.454

Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200094

Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25117811

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2014.454

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference